Cardiovascular diseases (CVDs) are the leading cause of death worldwide, with
atherosclerotic cardiovascular disease (ASCVD) being the dominant cause of total CVD …

HIV infection has transitioned from an acute, fatal disease to a chronic one managed by
antiretroviral therapy. Thus, the aging population of people living with HIV (PLWH) continues …

Background: Immune checkpoint inhibitors (ICIs) treat an expanding range of cancers.
Consistent basic data suggest that these same checkpoints are critical negative regulators of …

People with human immunodeficiency virus (HIV) have higher rates of certain comorbidities,
particularly cardiovascular disease and cancer, than people without HIV,,,–. In view of …

The evolution of antiretroviral therapies (ART) has tremendously improved the life
expectancy of people living with human immunodeficiency virus (HIV)(PLWH), which is …

Background People living with human immunodeficiency virus (PLHIV) are at increased risk
of atherosclerotic cardiovascular disease (ASCVD) and are prone to statin-related adverse …

Background The relationship of microbiota composition dynamics and the progression of
subclinical atherosclerosis in people with human immunodeficiency virus (PWH) remains …

Background: A high proportion of individuals with HIV have hypertension, and the incidence
of cardiovascular disease (CVD) is high in individuals with HIV. Methods: We determined if …

Objective: Inflammation is key in the pathogenesis of atherosclerotic coronary artery disease
(CAD). Distinct sex-specific inflammatory mechanisms may contribute to CAD in sub …

Background It is unclear whether HIV infection affects the long‐term prognosis after an acute
coronary syndrome (ACS). The objective of the current study was to compare rates of major …